← 返回

基于单细胞和基于 Transformer 的扰动揭示的结直肠癌中以配体为中心的γδ T 细胞激活框架

英文原题:A ligand-centered framework for γδ T cell activation in colorectal cancer revealed by single-cell and transformer-based perturbation.

查看英文原题

A ligand-centered framework for γδ T cell activation in colorectal cancer revealed by single-cell and transformer-based perturbation.

PubMed 2026/01/13(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

理解结直肠癌(CRC)中γδ T细胞的激活机制对于利用其治疗潜力至关重要。在此,我们通过整合多个单细胞RNA-seq数据集构建了人类CRC浸润γδ T细胞的图谱,并结合差异基因表达、基因调控网络预测、配体推断和计算机扰动分析,开发了一个γδ T细胞精细化的配体推断流程。该方法识别出包括IL-15和TNFSF9(4-1BBL)在内的配体作为促进γδ T细胞效应功能的候选因子,并突出了NCR2和KLRC3(NKG2E),其在计算机过表达与γδ T细胞激活相关。配体富集分析进一步表明,单核细胞和树突状细胞是肿瘤微环境中γδ T细胞激活的关键贡献者。

我们的结果还突出了在激活程度较低的γδ T细胞中的转录因子IKZF1、FOSL2和FOXO1,以及在效应γδ T细胞中的IRF1、KLF2和BHLHE40,这些转录因子可能调控了差异激活状态。

总之,我们的结果提供了调控CRC中γδ T细胞表型的信号和转录程序的系统层面视角,并为具有增强抗肿瘤功能的γδ T细胞免疫疗法提供了基础。

展开英文摘要原文

Understanding the activation mechanisms of γδ T cells in colorectal cancer (CRC) is critical for harnessing their therapeutic potential.

Here, using an atlas of human CRC-infiltrating γδ T cells that we built by integrating multiple single-cell RNA-seq datasets, we developed a γδ T cell-refined ligand inference pipeline by combining differential gene expression, gene regulatory network prediction, ligand inference, and in silico perturbation analysis.

This approach identified ligands, including IL-15 and TNFSF9 (4-1BBL), as candidates promoting γδ T cell effector function and highlighted NCR2 and KLRC3 (NKG2E), whose in silico overexpression was associated with γδ T cell activation. Ligand enrichment analyses further indicated that monocytes and dendritic cells are key contributors to γδ T cell activation in the tumor microenvironment.

Our results also highlighted transcription factors IKZF1, FOSL2, and FOXO1 in the less activated γδ T cells and IRF1, KLF2, and BHLHE40 in the effector γδ T cells that plausibly regulated the differential activation state.

Together, our results offer a systems-level view of the signaling and transcriptional programs governing γδ T cell phenotypes in CRC and provide a foundation for γδ T cell-based immunotherapies with enhanced antitumor functions.

论文信息

作者
Ran R、Brubaker DK
单位
Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University, Cleveland, OH, United States.United States
期刊
Frontiers in immunology2025
原文标识
PubMed 41607803 · DOI 10.3389/fimmu.2025.1715827